Esperion Therapeutics, Inc. (ESPR)

Esperion Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	144.76	82.25	124.78	208.89	304.96
Short-Term Investments	-	-	42.09	50.44	-
Cash & Short-Term Investments	144.76	82.25	166.86	259.33	304.96
Cash Growth	76.00%	-50.71%	-35.66%	-14.96%	51.89%
Receivables	80.14	48.49	33.73	22.93	12.39
Inventory	94.49	65.62	35.2	34.39	16.14
Prepaid Expenses	18.6	4.7	10.89	12.31	12.41
Total Current Assets	338	201.07	246.68	328.97	345.9
Property, Plant & Equipment	5.77	4.68	1.2	2.56	7.31
Other Intangible Assets	0.06	0.06	0.06	0.06	0.06
Other Long-Term Assets	-	-	-	50	-
Total Assets	343.82	205.8	247.94	381.59	353.26
Accounts Payable	51.65	31.72	23.04	17.56	51.98
Accrued Expenses	24.63	28.44	18.63	21.23	27.43
Current Portion of Long-Term Debt	102.16	34.83	24.76	11.3	5.39
Current Portion of Leases	2.74	1.55	0.38	1.39	2.59
Current Unearned Revenue	8.52	25.4	3.51	5.68	1.66
Other Current Liabilities	56.54	34.28	21.99	16.19	5.03
Total Current Liabilities	246.23	156.22	92.31	73.35	94.07
Long-Term Debt	483.74	501.55	478.74	504.02	350.58
Long-Term Leases	2.57	3.02	0.67	0.52	3.45
Long-Term Unearned Revenue	-	-	-	0.63	-
Other Long-Term Liabilities	-	-	-	-	1.29
Total Liabilities	732.54	660.79	571.72	578.53	449.39
Common Stock	0.2	0.12	0.08	0.06	0.03
Additional Paid-In Capital	1,267	1,149	1,071	964.4	797.66
Retained Earnings	-1,601	-1,549	-1,340	-1,106	-838.82
Treasury Stock	-55	-55	-55	-55	-55
Comprehensive Income & Other	-	-	-0	-0.03	-
Shareholders' Equity	-388.72	-454.99	-323.78	-196.94	-96.13
Total Liabilities & Equity	343.82	205.8	247.94	381.59	353.26
Total Debt	591.21	540.95	504.55	517.24	362.01
Net Cash (Debt)	-446.45	-458.7	-337.69	-257.9	-57.05
Net Cash Per Share	-2.39	-4.45	-5.09	-8.92	-2.08
Filing Date Shares Outstanding	197.85	185.05	76.57	62.82	27.94
Total Common Shares Outstanding	195.85	118.21	74.57	60.88	25.92
Working Capital	91.77	44.84	154.38	255.62	251.83
Book Value Per Share	-1.98	-3.85	-4.34	-3.23	-3.71
Tangible Book Value	-388.78	-455.05	-323.83	-197	-96.19
Tangible Book Value Per Share	-1.99	-3.85	-4.34	-3.24	-3.71
Machinery	0.86	0.86	1.45	1.45	1.45
Leasehold Improvements	0.19	0.19	0.3	0.3	0.3

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q